rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2008-5-27
|
pubmed:abstractText |
Endothelial lipase (EL), a new member of the triacylglycerol lipase family, modulates the metabolism of high-density lipoproteins and is upregulated by inflammatory cytokines. Since type 2 diabetes is associated with chronic subclinical inflammation, we have determined whether serum EL concentration is increased in type 2 diabetes and investigated the effect of insulin on EL.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1879-1484
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
198
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
441-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:18433755-Adult,
pubmed-meshheading:18433755-Aorta,
pubmed-meshheading:18433755-Diabetes Mellitus, Type 2,
pubmed-meshheading:18433755-Endothelium, Vascular,
pubmed-meshheading:18433755-Female,
pubmed-meshheading:18433755-Humans,
pubmed-meshheading:18433755-Hypoglycemic Agents,
pubmed-meshheading:18433755-Insulin,
pubmed-meshheading:18433755-Lipase,
pubmed-meshheading:18433755-Male,
pubmed-meshheading:18433755-Middle Aged,
pubmed-meshheading:18433755-RNA, Messenger
|
pubmed:year |
2008
|
pubmed:articleTitle |
Type 2 diabetes mellitus and endothelial lipase.
|
pubmed:affiliation |
Department of Medicine, University of Hong Kong, Queen Mary Hospital, Pokfulam Road, Hong Kong.
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|